The results of an early trial in 31 brain cancer patients finds immune activity boosted in the tumor, and possibly longer survival.

However, we have a group of ‘essential genes’ that we cannot remove because it results in cell death.” To overcome this, Adli and colleagues utilize reversible auxin-inducible degron (AID) tools that ...

Shipra Das, an immunooncologist at Cellectis, discussed a novel approach using transcription activation-like effector nucleases (TALENs) gene editing to overcome these shortcomings by making CAR T ...

New Rochelle, NY, February 19, 2025—A new study in the peer-reviewed Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I (RIG-I) agonist RNA ...

A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I (RIG-I) agonist RNA (RAR) induces innate immune signaling and death of ...